Archives for September 2007
Five New Needle-Free Delivery Devices
Despite physicians’ best efforts and parents’ reassurance, receiving a shot is a terrifying experience for a young child. And with an ever-increasing population of insulin-dependent diabetics requiring several injections a day, adults also would be pleased to learn of needle-free alternatives.
While needle-free injection technology has been around at least since the 1960s, when Aaron Ismach […]
OpGen Raises $23.6 Million for DNA Analysis Technology
OpGen, a Madison, WI-based company whose technology analyzes DNA extracted from microbial cells, has raised $23.6 million in a Series A equity financing. The financing — led by CHL Medical Partners, Highland Capital Partners and Versant
Ventures, with previous investor Mason Wells also participating — will be used to develop diagnostic systems for the clinical […]
$21.8 Million Series C for Vital Liver Treatment
Vital Therapies, a San Diego, CA-based company developing a human cell-based artificial liver, has completed a $21.8 million Series C financing. The money will go toward continued development of the company’s ELAD (Extracorporeal Liver Assist Device) System, which augments […]
Synergetics to Target Vitreoretinal Surgeons
Synergetics USA, based in O’Fallon, MO, has entered an agreement that grants the company exclusive U.S. distribution rights for retinal lenses and equipment made by Mentor, OH-based Volk Optical.
The three-year agreement includes Volk’s line of ophthalmic lenses, used for detailed examination and treatment of the retina, and Volk’s new Optiflex Surgical Assistant, which enhances surgeons’ […]
Biosafe, MedRespond and Blue Belt Tech Split $570K
MedRespond, Blue Belt Technologies and Biosafe are the latest companies to benefit from investments by The Pittsburgh Life Sciences Greenhouse (PLSG), a public/private partnership founded in 2001 to grow Southwestern Pennsylvania’s life sciences industry. The organization, which helps emerging companies build sustainable business models and secure capital, has committed $570,000 to the three firms.
MedRespond was […]
Consumer Demand Drives Aesthetic Market
Nearly five centuries after Ponce de León failed to locate the Fountain of Youth, medical technology has advanced to a stage where willing-and-able consumers can attain a forever youthful look. Wrinkles, once merely a sign of old age, now reflect differences in class and income — for those with deep pocketbooks, signs of aging can […]
UltraShape Secures $15.1 Million
UltraShape, a Palo Alto, CA, aesthetic company specializing in non-invasive body contouring, has completed a $15.1 million round of funding.
Led by new investor Meritech Capital Partners, with participation from previous institutional investors Israel Seed Partners and Polaris Venture Partners, the financing will go toward commercializing UltraShape’s Contour I system, selected earlier this year as the […]
Enova Forms Joint-Venture Orthopedics Company
Enova Medical Technologies, of St. Paul, MN, has teamed up with a footwear-development company to launch Exos Corporation, a joint-venture company that will make orthopedic support devices.
Exos will focus on the development and commercialization of a patent-pending technology called OrthoFoam Dry-Heat Thermoformable Splint/Cast/Brace Systems, developed by Enova’s partner in this venture, Aspen, CO-based Product […]
BioForce Nanosciences Completes Series A Financing
BioForce Nanosciences, an Ames, IA-based nanotechnology firm, has completed a $3.45 million Series A financing.
The money will go toward expanded sales and marketing for the company’s flagship product, the Nano eNabler, a benchtop molecular printer that is capable of “printing” extremely small tests; it allows for the deposition of minute quantities of liquids at defined […]
CardioDynamics Completes Sale of Vermed
CardioDynamics, a San Diego-based company that uses impedance cardiography (ICG) technology to monitor the heart’s ability to deliver blood to the body, has completed the sale of its Vermed business unit for $8 million. The unit was sold to Medical Device Partners, a Vermont corporation formed by Vermed’s management team.
The decision to sell Vermed, announced […]
